_256_384.jpg)
In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020
Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has has 10 existing labs in India
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Subscribe To Our Newsletter & Stay Updated
